Brooks-Worrell Barbara M, Iyer Dinakar, Coraza Ivonne, Hampe Christiane S, Nalini Ramaswami, Ozer Kerem, Narla Radhika, Palmer Jerry P, Balasubramanyam Ashok
Corresponding authors: Barbara M. Brooks-Worrell,
Diabetes Care. 2013 Dec;36(12):4098-103. doi: 10.2337/dc12-2328. Epub 2013 Oct 15.
Ketosis-prone diabetes (KPD) is characterized by diabetic ketoacidosis (DKA) in patients lacking typical features of type 1 diabetes. A validated classification scheme for KPD includes two autoantibody-negative ("A-") phenotypic forms: "A-β-" (lean, early onset, lacking β-cell functional reserve) and "A-β+" (obese, late onset, with substantial β-cell functional reserve after the index episode of DKA). Recent longitudinal analysis of a large KPD cohort revealed that the A-β+ phenotype includes two distinct subtypes distinguished by the index DKA episode having a defined precipitant ("provoked," with progressive β-cell function loss over time) or no precipitant ("unprovoked," with sustained β-cell functional reserve). These three A- KPD subtypes are characterized by absence of humoral islet autoimmune markers, but a role for cellular islet autoimmunity is unknown.
Islet-specific T-cell responses and the percentage of proinflammatory (CD14+CD16+) blood monocytes were measured in A-β- (n = 7), provoked A-β+ (n = 15), and unprovoked A-β+ (n = 13) KPD patients. Genotyping was performed for type 1 diabetes-associated HLA class II alleles.
Provoked A-β+ and A-β- KPD patients manifested stronger islet-specific T-cell responses (P < 0.03) and higher percentages of proinflammatory CD14+CD16+ monocytes (P < 0.01) than unprovoked A-β+ KPD patients. A significant relationship between type 1 diabetes HLA class II protective alleles and negative T-cell responses was observed.
Provoked A-β+ KPD and A-β- KPD are associated with a high frequency of cellular islet autoimmunity and proinflammatory monocyte populations. In contrast, unprovoked A-β+ KPD lacks both humoral and cellular islet autoimmunity.
酮症倾向糖尿病(KPD)的特征是在缺乏1型糖尿病典型特征的患者中出现糖尿病酮症酸中毒(DKA)。一种经过验证的KPD分类方案包括两种自身抗体阴性(“A-”)表型形式:“A-β-”(体型消瘦、起病早、缺乏β细胞功能储备)和“A-β+”(肥胖、起病晚,在DKA首发事件后具有大量β细胞功能储备)。最近对一个大型KPD队列的纵向分析显示,A-β+表型包括两种不同的亚型,其区别在于首发DKA事件有明确的诱发因素(“有诱因的”,随着时间推移β细胞功能逐渐丧失)或无诱发因素(“无诱因的”,具有持续的β细胞功能储备)。这三种A-KPD亚型的特征是缺乏体液胰岛自身免疫标志物,但细胞胰岛自身免疫的作用尚不清楚。
在A-β-(n = 7)、有诱因的A-β+(n = 15)和无诱因的A-β+(n = 13)KPD患者中测量胰岛特异性T细胞反应和促炎(CD14+CD16+)血液单核细胞的百分比。对1型糖尿病相关的HLA II类等位基因进行基因分型。
与无诱因的A-β+ KPD患者相比,有诱因的A-β+和A-β- KPD患者表现出更强的胰岛特异性T细胞反应(P < 0.03)和更高比例的促炎CD14+CD16+单核细胞(P < 0.01)。观察到1型糖尿病HLA II类保护性等位基因与阴性T细胞反应之间存在显著关系。
有诱因的A-β+ KPD和A-β- KPD与细胞胰岛自身免疫和促炎单核细胞群体的高频率相关。相比之下,无诱因的A-β+ KPD缺乏体液和细胞胰岛自身免疫。